Edition:
United Kingdom

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

8.28USD
22 Apr 2019
Change (% chg)

-- (--)
Prev Close
$8.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
53,157
52-wk High
$18.00
52-wk Low
$3.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.849
Sep '18 0.00 -0.799
Jun '18 0.00 -1.980
Mar '18 0.00 -2.881
FY 2017 Dec '17 0.25 -2.366
Sep '17 0.25 -3.110
Jun '17 0.00 -3.200
Mar '17 0.00 -4.125
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 2 0.00 0.00 0.00 0.00
Quarter Ending Sep-19 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Year Ending Dec-20 2 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-19 3 -0.68 -0.52 -0.93 -2.90
Quarter Ending Sep-19 3 -0.70 -0.52 -0.98 -3.40
Year Ending Dec-19 3 -2.67 -2.09 -3.43 -11.86
Year Ending Dec-20 3 -2.35 -2.02 -2.68 -15.83
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 109.48 62.40
P/E High - Last 5 Yrs. -- 163.07 56.31
P/E Low - Last 5 Yrs. -- 52.30 28.72
Beta 1.77 1.16 0.93
Price to Sales (TTM) -- 46.04 9.62
Price to Book (MRQ) 1.69 13.22 4.53
Price to Tangible Book (MRQ) 2.72 18.84 7.71
Price to Cash Flow (TTM) -- 73.00 43.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.09 1.54
Dividend Yield - 5 Year Avg -- 0.05 0.70
Dividend 5 Year Growth Rate -- 0.72 2.97
Payout Ratio(TTM) -- 8.42 21.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 23.35 9.20
Sales (TTM) vs TTM 1 Yr. Ago -100.00 67.54 8.35
Sales - 5 Yr. Growth Rate -- 33.23 11.12
EPS (MRQ) vs Qtr. 1 Yr. Ago 64.12 -90.23 110.61
EPS (TTM) vs TTM 1 Yr. Ago 49.15 -- --
EPS - 5 Yr. Growth Rate -- 21.68 6.92
Capital Spending - 5 Yr. Growth Rate -- 25.56 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.71 2.66
Current Ratio (MRQ) 9.33 3.55 3.63
LT Debt to Equity (MRQ) 0.00 7.07 13.26
Total Debt to Equity (MRQ) 0.00 20.06 16.97
Interest Coverage (TTM) -89.72 10.02 27.27

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 25.18 50.31
Gross Margin - 5 Yr. Avg. -- 59.97 50.77
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -28,219.00 -10.84 15.78
Operating Margin (TTM) -- -109.08 -2.09
Operating Margin - 5 Yr. Avg. -28,472.60 -26.44 11.11
Pre-Tax Margin (TTM) -- -109.66 -2.92
Pre-Tax Margin - 5 Yr. Avg. -28,761.60 -29.17 16.76
Net Profit Margin (TTM) -- -116.04 -6.86
Net Profit Margin - 5 Yr. Avg. -28,761.60 -34.35 11.72
Effective Tax Rate (TTM) -- 19.91 22.86
Effective Tax Rate - 5 Yr. Avg. -- 19.61 23.86

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 8,511,584 773,166,387
Net Income/Employee (TTM) -1,077,917 1,995,061 89,056,262
Receivable Turnover (TTM) -- 2.36 5.22
Inventory Turnover (TTM) -- 2.31 3.65
Asset Turnover (TTM) 0.00 0.32 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -90.67 6.35 9.54
Return on Assets - 5 Yr. Avg. -82.97 6.24 10.49
Return on Investment (TTM) -110.37 7.96 11.78
Return on Investment - 5 Yr. Avg. -100.27 8.16 13.39
Return on Equity (TTM) -110.71 8.11 12.61
Return on Equity - 5 Yr. Avg. -1,483.02 9.28 14.86
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 59.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catabasis Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 8.58 6.70 99 90
13 Week 21.08 9.86 99 74
26 Week 17.14 11.64 99 4
52 Week -55.25 -58.27 50 26
YTD 85.35 59.95 99 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 33.41%
# of Holders: 29
Total Shares Held: 3,840,572
3 Mo. Net Change: 1,328,088
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 0
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.